GLP-1 weight loss injections are FDA-approved for chronic weight management and have an excellent safety profile when administered under medical supervision
What the Data Shows The SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, randomized 2,539 adults with obesity to tirzepatide at 5, 10, or 15 mg weekly or placebo for 72 weeks (3)
doi: 10.2337/db13-1440 28 HadjiyanniIBaggioLLPoussierPDruckerDJ
According to a National Institutes of Health study, exposure to cues related to food, including advertisements or the sight of food, greatly heightens appetites for food, particularly high-calorie foods
As a scientifically validated method for managing chronic weight issues, semaglutide aids in significant weight reduction by mimicking the body's natural hormone, GLP-1
These effects make Tirzepatide remarkably effective for fat loss